CCL5 and neoplasm: Because mouse CCR5 differs significantly from human CCR5 30, it cannot function as a chemoattractant receptor for CCL5; thus, xenograft tumour model was insufficient to permit the entry of monocytes into the tumour for differentiation to TAM.